Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Francesco Forfori and Abele Donati.
Francesco Forfori
Connection Strength
0.174
Abele Donati
  1. Rationale for Polyclonal Intravenous Immunoglobulin Adjunctive Therapy in COVID-19 Patients: Report of a Structured Multidisciplinary Consensus. J Clin Med. 2021 Aug 08; 10(16).
    View in: PubMed
    Score: 0.060
  2. Adjunctive IgM-enriched immunoglobulin therapy with a personalised dose based on serum IgM-titres versus standard dose in the treatment of septic shock: a randomised controlled trial (IgM-fat trial). BMJ Open. 2021 02 11; 11(2):e036616.
    View in: PubMed
    Score: 0.058
  3. Multi-centre, three arm, randomized controlled trial on the use of methylprednisolone and unfractionated heparin in critically ill ventilated patients with pneumonia from SARS-CoV-2 infection: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Aug 17; 21(1):724.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.